Database of Interstitial Lung Diseases

Sponsor
St. Antonius Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT00267800
Collaborator
(none)
100,000
4
25000

Study Details

Study Description

Brief Summary

The cause of most interstitial lung diseases (ILDs) is still unknown. Further research, for example to determine predisposing genetic factors, is therefore needed. A database with relevant clinical data and DNA/serum samples of ILD patients could facilitate future research on the cause of ILDs.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Protocol title: 'Registration of clinical data and DNA of patients with Interstitial Lung Disease (ILD)' Rationale: The etiopathogenesis of most Interstitial Lung Diseases (ILDs) is still unknown. Further research, e.g. to determine predisposing genetic factors, is therefore needed. A database with relevant clinical data and DNA/serum samples of ILD patients could facilitate future research on the etiopathogenesis of ILDs.

    Objective: Availability of relevant clinical data and DNA/serum samples of ILD patients in a database. Those data can be used for future research.

    Study design: A prospective observational study

    Study population: Patients diagnosed with ILD attending the pulmonology department in participating hospitals.

    Intervention: a blood sample is taken from each patient. Furthermore, additional information is collected from the medical file.

    Main study parameters/endpoints: DNA and serum sample, demographic variables, medical information, occupational history and hobbies.

    Nature and extent of the burden and risks associated with participation, group relatedness:

    two tubes of blood will be drawn from the patients. The risks of drawing blood from a vein are minimal.

    Study Design

    Study Type:
    Observational
    Official Title:
    Registration of Clinical Data and DNA/Serum of Patients With Interstitial Lung Diseases (ILD)
    Study Start Date :
    Jan 1, 2006

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • Diagnosis of an ILD, as stated by the American Thoracic Society (ATS)

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 St. Antonius Hospital Nieuwegein Netherlands 3435CM
      2 Diakonessenhuis Utrecht Netherlands 3508 TG
      3 Mesos Medisch Centrum Utrecht Netherlands 3527 CE
      4 UMC Utrecht Utrecht Netherlands 3584 CX

      Sponsors and Collaborators

      • St. Antonius Hospital

      Investigators

      • Principal Investigator: J.M.M. van den Bosch, M.D., St. Antonius Hospital
      • Principal Investigator: J.C. Grutters, M.D., St. Antonius Hospital

      Study Documents (Full-Text)

      None provided.

      More Information

      Additional Information:

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00267800
      Other Study ID Numbers:
      • R05.08/A
      First Posted:
      Dec 21, 2005
      Last Update Posted:
      Aug 8, 2008
      Last Verified:
      Dec 1, 2005

      Study Results

      No Results Posted as of Aug 8, 2008